Security National Bank Amgen Inc Transaction History

Security National Bank

  • $636 Million
  • Q3 2025

A detailed history of Security National Bank transactions in Amgen Inc stock. As of the latest transaction made, Security National Bank holds 1,759 shares of AMGN stock, worth $601,067. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,759
Previous 1,440 22.15%
Holding current value
$601,067
Previous $402,000 23.38%
% of portfolio
0.08%
Previous 0.07%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 20, 2025
BUY
$271.18 - $309.22 $86,506 - $98,641
319 Added 22.15%
1,759 $496,000
Q2 2025

Jul 10, 2025
SELL
$262.28 - $309.85 $262,280 - $309,850
-1,000 Reduced 40.98%
1,440 $402,000
Q1 2025

Apr 23, 2025
BUY
$258.59 - $327.36 $258,589 - $327,360
1,000 Added 69.44%
2,440 $760,000
Q4 2024

Feb 10, 2025
SELL
$258.78 - $328.31 $80,739 - $102,432
-312 Reduced 17.81%
1,440 $375,000
Q2 2024

Jul 22, 2024
SELL
$262.75 - $319.31 $9,984 - $12,133
-38 Reduced 2.12%
1,752 $547,000
Q1 2024

Apr 15, 2024
SELL
$268.87 - $324.56 $2,688 - $3,245
-10 Reduced 0.56%
1,790 $508,000
Q3 2023

Oct 20, 2023
SELL
$218.65 - $271.46 $3,935 - $4,886
-18 Reduced 0.99%
1,800 $483,000
Q2 2023

Jul 18, 2023
SELL
$214.27 - $253.37 $41,354 - $48,900
-193 Reduced 9.6%
1,818 $403,000
Q1 2023

Apr 17, 2023
SELL
$225.79 - $275.2 $53,963 - $65,772
-239 Reduced 10.62%
2,011 $486,000
Q4 2022

Feb 01, 2023
SELL
$229.03 - $291.01 $13,283 - $16,878
-58 Reduced 2.51%
2,250 $590,000
Q3 2022

Oct 18, 2022
SELL
$224.46 - $253.15 $15,038 - $16,961
-67 Reduced 2.82%
2,308 $520,000
Q2 2022

Jul 25, 2022
SELL
$230.71 - $256.74 $84,439 - $93,966
-366 Reduced 13.35%
2,375 $578,000
Q1 2022

Apr 25, 2022
SELL
$219.27 - $242.57 $128,053 - $141,660
-584 Reduced 17.56%
2,741 $663,000
Q4 2021

Jan 28, 2022
BUY
$198.88 - $227.6 $42,361 - $48,478
213 Added 6.84%
3,325 $748,000
Q3 2021

Oct 14, 2021
SELL
$212.27 - $248.7 $12,099 - $14,175
-57 Reduced 1.8%
3,112 $662,000
Q2 2021

Jul 07, 2021
SELL
$233.58 - $259.14 $5.71 Million - $6.34 Million
-24,464 Reduced 88.53%
3,169 $772,000
Q1 2021

Apr 05, 2021
BUY
$221.91 - $258.6 $909,609 - $1.06 Million
4,099 Added 17.42%
27,633 $6.88 Million
Q4 2020

Feb 01, 2021
SELL
$216.38 - $257.67 $168,992 - $201,240
-781 Reduced 3.21%
23,534 $5.41 Million
Q3 2020

Oct 19, 2020
BUY
$234.65 - $260.95 $299,413 - $332,972
1,276 Added 5.54%
24,315 $6.18 Million
Q2 2020

Aug 11, 2020
BUY
$197.81 - $242.74 $230,250 - $282,549
1,164 Added 5.32%
23,039 $5.43 Million
Q1 2020

Apr 21, 2020
BUY
$182.24 - $241.7 $99,138 - $131,484
544 Added 2.55%
21,875 $4.44 Million
Q4 2019

Feb 04, 2020
BUY
$189.21 - $243.2 $37,652 - $48,396
199 Added 0.94%
21,331 $5.14 Million
Q3 2019

Oct 15, 2019
BUY
$174.11 - $208.62 $64,246 - $76,980
369 Added 1.78%
21,132 $4.09 Million
Q2 2019

Jul 22, 2019
BUY
$166.7 - $195.41 $140,528 - $164,730
843 Added 4.23%
20,763 $3.83 Million
Q1 2019

May 14, 2019
BUY
$180.87 - $203.88 $216,682 - $244,248
1,198 Added 6.4%
19,920 $3.78 Million
Q4 2018

Feb 14, 2019
BUY
$178.4 - $208.25 $247,440 - $288,842
1,387 Added 8.0%
18,722 $3.65 Million
Q3 2018

Oct 15, 2018
BUY
$185.29 - $208.89 $87,271 - $98,387
471 Added 2.79%
17,335 $3.59 Million
Q2 2018

Jul 26, 2018
BUY
$166.05 - $186.51 $107,102 - $120,298
645 Added 3.98%
16,864 $3.11 Million
Q1 2018

May 09, 2018
SELL
$169.43 - $198.0 $34,394 - $40,194
-203 Reduced 1.24%
16,219 $2.77 Million
Q4 2017

Feb 13, 2018
BUY
$168.79 - $188.59 $5,063 - $5,657
30 Added 0.18%
16,422 $2.86 Million
Q3 2017

Nov 13, 2017
BUY
$167.29 - $191.0 $37,305 - $42,593
223 Added 1.38%
16,392 $3.06 Million
Q2 2017

Jan 03, 2018
BUY
N/A
703 Added 4.55%
16,169 $2.79 Million
Q1 2017

Jan 04, 2018
BUY
N/A
15,466
15,466 $2.54 Million

Others Institutions Holding AMGN

# of Institutions
3,269
Shares Held
428M
Call Options Held
6.17M
Put Options Held
5.85M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Security National Bank Portfolio

Follow Security National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Security National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Security National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email